Do Traders Think Soleno Therapeutics Inc (SLNO) Can Keep Climbing Thursday?

Soleno Therapeutics Inc (SLNO) stock is higher by 5.88% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Soleno Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SLNO!

See Full SLNO Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SLNO Stock Today?

Soleno Therapeutics Inc (SLNO) stock is trading at $0.18 as of 11:55 AM on Thursday, Jun 30, a loss of -$0.02, or -9.41% from the previous closing price of $0.20. The stock has traded between $0.18 and $0.20 so far today. Volume today is below average. So far 529,755 shares have traded compared to average volume of 1,848,178 shares. To see InvestorsObserver's Sentiment Score for Soleno Therapeutics Inc click here.

More About Soleno Therapeutics Inc

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. Click Here to get the full Stock Report for Soleno Therapeutics Inc stock.